![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 2
2022
Schmidt-Kraepelin, Christian; Feyerabend, Sandra; Engelke, Christina; Riesbeck, Mathias; Meisenzahl-Lechner, Eva; Verde, Pablo-Emilio; Correll, Christoph U.; Kluge, Michael; Makiol, Christian; Neff, Andrea; Lange, Christina; Englisch, Susanne; Zink, Mathias; Langguth, Berthold; Poeppl, Timm B.; Reske, Dirk; Gouzoulis-Mayfrank, Euphrosyne; Gruender, Gerhard; Hasan, Alkomiet; Brockhaus-Dumke, Anke; Jaeger, Markus; Baumgaertner, Jessica; Leucht, Stefan und Cordes, Joachim
(2022):
Amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill patients with schizophrenia in Germany (COMBINE): a double-blind randomised controlled trial.
In: Lancet Psychiatry, Bd. 9, Nr. 4: S. 291-306
2020
Schmidt-Kraepelin, Christian; Feyerabend, Sandra; Engelke, Christina; Riesbeck, Mathias; Meisenzahl-Lechner, Eva; Gaebel, Wolfgang; Verde, Pablo-Emilio; Kolbe, Henrike; Correll, Christoph U.; Leucht, Stefan; Heres, Stephan; Kluge, Michael; Makiol, Christian; Neff, Andrea; Lange, Christina; Englisch, Susanne; Zink, Mathias; Langguth, Berthold; Poeppl, Timm; Reske, Dirk; Gouzoulis-Mayfrank, Euphrosyne; Gruender, Gerhard; Hasan, Alkomiet; Brockhaus-Dumke, Anke; Jaeger, Markus; Baumgaertner, Jessica; Wobrock, Thomas und Cordes, Joachim
(2020):
A randomized double-blind controlled trial to assess the benefits of amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill schizophrenia patients (COMBINE): methods and design.
In: European Archives of Psychiatry and Clinical Neuroscience, Bd. 270, Nr. 1: S. 83-94